PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1998686
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1998686
Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
The Global Heart-lung Machine Market was valued at USD 385.3 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 606.7 million by 2035.
The market expansion is driven primarily by the rising prevalence of cardiovascular diseases and the increasing number of organ transplants and open-heart surgeries worldwide. Heart-lung machines, also referred to as cardiopulmonary bypass (CPB) devices, temporarily assume the functions of the heart and lungs during surgery by oxygenating blood, removing carbon dioxide, and maintaining circulation. Technological innovations, including improved oxygenator systems and advanced blood pump designs, have enhanced efficiency, safety, and usability. Compact and high-performance devices are now enabling more precise circulation control, reduced surgical complications, and broader adoption in diverse healthcare settings. The growing demand for minimally invasive procedures, coupled with improved perioperative outcomes, continues to propel the use of heart-lung machines globally. Additionally, better reimbursement frameworks, expanding outpatient surgical facilities, and strategic investments by key players are supporting steady market growth.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $385.3 Million |
| Forecast Value | $606.7 Million |
| CAGR | 4.7% |
The single roller pump segment is expected to grow at a CAGR of 4.4% to reach USD 354 million by 2035. Its popularity stems from reliable, controlled blood flow, cost-effectiveness, and widespread use in cardiac surgeries. These pumps offer stable extracorporeal membrane oxygenation, which is crucial for procedures requiring prolonged circulation, making them a preferred choice across hospitals and emerging healthcare facilities.
The ambulatory surgical centers segment accounted for USD 145.6 million in 2025 and is projected to reach USD 243 million by 2035, growing at a CAGR of 5.3%. Growth in this segment is fueled by the increasing adoption of minimally invasive cardiac procedures in outpatient settings, alongside compact, cost-efficient heart-lung machine solutions that support efficient perioperative care.
U.S. Heart-lung Machine Market reached USD 144.6 million in 2025 and is expected to grow at a CAGR of 4.1% from 2026 to 2035. High annual cardiac surgery volumes, favorable reimbursement policies, substantial R&D investment, and the presence of major manufacturers strengthen the U.S. position as a leading market for heart-lung machines.
Prominent players operating in the Global Heart-lung Machine Market include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, Hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, Raumedic, and TERUMO. Key strategies adopted by companies in the Global Heart-lung Machine Market include continuous R&D for advanced oxygenation and pump technologies, development of compact and portable devices for outpatient facilities, strategic partnerships with hospitals and surgical centers, expansion of global distribution networks, and ensuring regulatory compliance across multiple regions. Firms also focus on offering training programs, technical support, and after-sales services to improve adoption and customer loyalty, while optimizing production efficiency and supply chains to enhance competitiveness and market penetration.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation for any one approach
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Type trends
- 2.2.3 Application
- 2.2.4 End use trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of cardiovascular disease
- 3.2.1.2 Growing number of organ transplant surgeries
- 3.2.1.3 Technological advancements in heart-lung machines
- 3.2.1.4 Rising geriatric population base
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost of advanced heart-lung machines
- 3.2.2.2 Availability of alternative and minimally invasive procedures
- 3.2.3 Market opportunities
- 3.2.3.1 Expansion of transplant programs boosting requirements for advanced perfusion systems
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.5 Technology landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
- 3.6 Future market trends (Driven by Primary Research)
- 3.7 Pricing analysis, 2025 (Driven by Primary Research)
- 3.8 Impact of AI and generative AI on the market
- 3.9 Customer insights (Driven by Primary Research)
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
- 3.12 Gap analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
- 4.3.4 Asia Pacific
- 4.4 Competitive positioning matrix
- 4.5 Competitive analysis of major market players
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product type launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Single roller pump
- 5.3 Double roller pump
Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Cardiac surgeries
- 6.3 Lung surgeries
- 6.4 Acute respiratory failure treatment
- 6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals and clinics
- 7.3 Ambulatory surgical centers
- 7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 BRAILE
- 9.2 Edwards
- 9.3 ELITE LIFE CARE
- 9.4 EUROSETS
- 9.5 FRESENIUS MEDICAL CARE
- 9.6 GETINGE
- 9.7 HEART CARE INDIA CO
- 9.8 hemovent
- 9.9 Jarvik HEART
- 9.10 LivaNova
- 9.11 Medtronic
- 9.12 NIPRO
- 9.13 Palex
- 9.14 Philips
- 9.15 raumedic
- 9.16 TERUMO
